# How the Intermediate Product Rule Hemp Affects CBD Production

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/intermediate-product-rule-hemp-cbd-manufacturing-challenges/
> **Published:** 2026-02-23T12:52:53-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:15:04-04:00
> **Clinical Summary:** Explore how the intermediate product rule hemp creates legal challenges for CBD manufacturing under container limit regulations.

---

CED Clinical Relevance
 #15
 [Clinical Context](https://cedclinic.com/cannabis-hyperemesis-syndrome-treatment-insights-2026/)
 Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape.

PolicyCBDHempIndustrySafety

 Why This Matters
 Even if the CBD gummy in your hand is legal, the liquid used to manufacture it may not be—meaning American CBD production could be forced offshore or shut down entirely.

 Clinical Summary
 

Adam Terry, CEO of hemp beverage company Cantrip, explains a critical flaw: even if individually wrapped gummies could contain 0.4mg THC, the liquid used to make the molds would exceed the container limit on intermediates—making them illegal to manufacture in the US. The intermediate product rule means CBD crude and distillate routinely exceed 0.3% total THC during processing, even when the final product is non-intoxicating. Full-spectrum CBD needs comprehensive reform.

 Dr. Caplan’s Take
 “This is the most underreported crisis in the entire hemp debate: the law makes it legal to sell CBD but potentially illegal to make it, which is regulatory absurdity of the highest order.”

 Clinical Perspective
 

THE INTERMEDIATE PRODUCT TRAP: HOW THE HEMP BAN KILLS CBD MANUFACTURING

Most coverage of the November hemp ban focuses on final products—gummies, seltzers, tinctures. But the real threat to American CBD manufacturing is hiding in the fine print: the intermediate product rule.

Here’s the problem. During extraction and refinement, virtually all CBD crude and distillate routinely exceeds 0.3% total THC on a weight basis, even when the final bottled product falls well below the limit. Under the new law, those intermediate materials are no longer hemp. They’re [controlled substances](https://cedclinic.com/dea-scheduling-cannabis-policy-march-15-2026/).

As industry analyst Deb Tharp explained it: ‘Your stainless steel tank on the way there is suddenly on the wrong side of federal law.’ Even if your end product is non-intoxicating CBD, the stuff you’re processing is now illegal.

Adam Terry, CEO of hemp beverage company Cantrip, drives the point home with a specific example: even if individually wrapped gummies could contain 0.4mg THC each, the liquid used to pour into molds would exceed the container limit. Result: legal to sell, illegal to make.

This isn’t a hypothetical edge case. It’s the fundamental economics of CBD extraction. Full-spectrum CBD production requires intermediate steps that will, by definition, violate the new law. Without comprehensive reform, American CBD manufacturing may be forced offshore.

 

Have thoughts on this? Share it:

 
 [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Hemp+Beverage+CEO%3A+Even+Legal+Gummies+Would+Be+Illegal+to+MAKE+Under+Container+Rules+%40drcaplan&url=https%3A%2F%2Ffiltermag.org%2Ffda-cannabinoid-deadline-hemp%2F)
 [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Ffiltermag.org%2Ffda-cannabinoid-deadline-hemp%2F)
 [🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Hemp+Beverage+CEO%3A+Even+Legal+Gummies+Would+Be+Illegal+to+MAKE+Under+Container+Rules+%E2%80%94+via+%40drcaplan.bsky.social+https%3A%2F%2Ffiltermag.org%2Ffda-cannabinoid-deadline-hemp%2F)
 [📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)
 [📝 Read more on Substack](https://substack.com/@doctorapproved)
 [🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/)
 

 Related Articles
 
- [Hemp Beverage Companies Face Existential Threat Under 0.4mg THC Container Limit](https://cedclinic.com/hemp-beverage-industry-regulation-federal-thc-limits/)

 

💬 Join the Conversation

 

Have a question about how this applies to your situation?
 [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

 

Want to discuss this topic with other patients and caregivers?
 [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/)

📰 Source: [https://filtermag.org/fda-cannabinoid-deadline-hemp/](https://filtermag.org/fda-cannabinoid-deadline-hemp/)

 
 
 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

 
 Physician-Led, Whole-Person Care
 A doctor who takes the time to truly understand you.
 Personal care that starts with listening and is guided by experience and ingenuity.

 
 Health, Longevity, Wellness
 One-on-One Cannabis Guidance
 Metabolic Balance
 

 
 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 
 

 
 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[The Best CBD for Immune Support and Daily Resilience in 2026](https://cedclinic.com/the-best-cbd-for-immune-support-and-daily-resilience-in-2026-stupiddope-est-2008/)

Discover top [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/) that support immune health and resilience in 2026, highlighting quality and safety standards.

[Explore CBD Options](https://cedclinic.com/the-best-cbd-for-immune-support-and-daily-resilience-in-2026-stupiddope-est-2008/)

[Buy GREEN: A Field Guide To Marijuana Each Book Online](https://cedclinic.com/buy-marijuana-field-guide-online-green-cannabis-book/)

A comprehensive guide to marijuana, covering cultivation, legal issues, and industry insights for enthusiasts and professionals.

[Get the Guide](https://cedclinic.com/buy-marijuana-field-guide-online-green-cannabis-book/)

[Bemidji Chamber Ambassadors Welcome Coconut Cannabis](https://cedclinic.com/bemidji-chamber-ambassadors-welcome-coconut-cannabis/)

Learn about the latest developments in the [cannabis industry](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) with the Bemidji Chamber's support for Coconut Cannabis.

[Read More](https://cedclinic.com/bemidji-chamber-ambassadors-welcome-coconut-cannabis/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).
